Craig Adam R
Craig Adam R, CHAIR, reported an open-market or private purchase at X4 Pharmaceuticals, Inc involving 4600.000000 shares for an estimated $11883.64. Reported holdings after the transaction were 333251.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 16, 2026
- Filing date
- Oct 19, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 328,651 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
XFOR price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001339498-26-000005 Common Stock
- Transaction date
- Oct 16, 2026 Filed Oct 19, 2026, 08:06 PM · 3d delay
- Shares
- 4,600 sh $2.58 per share
- Estimated value
- $11.8k Computed from shares × price
- Holdings after
- 333,251 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+24 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - director_buy+6 points
is_director = true
Director open-market purchase.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Executive Chairman
- F1
Of the shares of common stock reported, 193,254 shares represent restricted stock units.
- F2
The Reporting Person has agreed to disgorge to the Issuer all profits deemed to be realized from this transaction pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.
0 other transactions
0 recent txs